Although there are relatively few cases of STAT5 mutation reported in human cancers and most of the aberrant activation of STAT5 is caused by mutations in upstream kinases, there are still some recent discoveries and identification of STAT5 mutations in patients leading to increased phosphorylation and activation of STAT5. Here, STAT5B is linked to cancer.